Type 2 Diabetes Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who were previously enrolled in and completed the evaluation phase of a specific earlier study called the EPSONIP trial (NCT03864510).
- People who are 18 years of age or older.
- People who have given their informed consent to take part in the trial.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People for whom an MRI (magnetic resonance) scan is not safe or suitable, for example due to certain metal implants or other medical reasons (confirm with trial site).
- People who have been diagnosed with a primary liver disease other than MASLD (a specific type of liver condition) after joining the earlier EPSONIP trial.
- People who have had a liver transplant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prevalence of MASLD; Progression/regression of MASLD; Predictors of MASLD progression/regression; Prevalence of advanced fibrosis; Progression/regression of advanced fibrosis; Predictors of fibrosis progression/regression; The association between physical activity and prevalent advanced fibrosis; The association between physical activity and risk of progressing to advanced fibrosis; Genetic factors associated with advanced fibrosis or MASLD progression/regression; Association between body composition and MASLD and/or liver fibrosis and progression/regression thereof
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.